Biotech, Diagnostics, Life Sciences
Insilicos Wins $400K NIH Grant
Luke Timmerman 2/4/09
Insilicos, a Seattle-based company that makes software for drug researchers, has received a $400,000 grant from the National Institutes of Health to study a statistical method for predicting disease. The grant will support the company’s work on Least Angle Regression, says Insilicos president Erik Nilsson, in an e-mail. This is the second grant for Insilicos since December, when the company received a $900,000 award from the NIH to study a blend of statistical models.
Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.
